Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

A Phase 3, Open-Label Study Evaluating the Long-Term Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis (IRB 274469)


Collapse Overview 
Collapse sponsor award id
VX20-121-104


Collapse Biography 

Collapse Time 
Collapse start date
2022-10-04

Collapse end date
2032-10-03